FDA Import Refusal 1FX-6845078-2/30002/1 — GLAXOSMITHKLINE PHARMA LIMITED
The FDA refused shipment 1FX-6845078-2/30002/1 from GLAXOSMITHKLINE PHARMA LIMITED (India) on Sep 14, 2026. The refused product falls under Drugs and Biologics — MUPIROCIN (ANTI-BACTERIAL, PART II) (NOT ANTIBIOTIC). Cited charge: 75 This firm has 2 other import refusals on record.
Refusal Details
- Date
- Sep 14, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61GCJ81 MUPIROCIN (ANTI-BACTERIAL, PART II) (NOT ANTIBIOTIC)
- Charges
- 75